Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
fig.2.k, l
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF16 (in situ hybridization) |
|
||||
fig.1.c
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF17 (in situ hybridization) |
|
||||
fig.7.i, i^1
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF20 (in situ hybridization) |
|
||||
fig.6.b, f
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF20-22 (in situ hybridization) |
|
||||
fig.1.o
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF28 (immunohistochemistry) |
|
||||
fig.1.o
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF28 (in situ hybridization) |
|
||||
fig.1.i, l
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF35/36 (immunohistochemistry) |
|
||||
fig.1.i
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF35/36 (in situ hybridization) |
|
||||
fig.1.l
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF35/36 (in situ hybridization) |
|